• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Hong Kong·Healthcare·0383.HK
Share

Tian An Medicare Limited Stocks

HK$ 0.85Last Updated 19.11.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

HK$ 106.49M

HK$ 0.85
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Poor growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Tian An Medicare Limited operates as an investment holding company with its core business centered on managing hospitals across the People's Republic of China, Australia, and the Philippines. The company organizes its diverse activities into six principal segments: Healthcare, Eldercare, Property Development, Property Investment, Financial Services, and Securities Trading and Investments. Beyond its hospital operations, the group is involved in the development of independent living units and oversees the project management of health campuses dedicated to elderly care and retirement communities. These comprehensive facilities encompass elderly nursing homes, service apartments, independent living units, a shopping mall, various retail shops, and club amenities. Furthermore, the company develops and divests properties and land parcels, leases out residential and commercial office properties, provides money lending services, and delivers additional healthcare provisions. Its scope also extends to the trade of medical apparatus and related supplies, alongside engaging in the buying and selling of securities listed on international exchanges. Its corporate headquarters are located in Wanchai, Hong Kong.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is overpriced on P/E, of fair value o

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

20.11.2026 13:46

Not Waiting for the Bottom: Burry Bought More of Tencent, BYD, and Adobe Shares as Their Prices Fell

20.11.2026 13:23

The short seller who highlighted Nvidia's problems has set his sights on a new target: Cerebras shares

20.11.2026 12:57

Stress Test: Which Nvidia Suppliers Will Be Hit Hardest After Huang's Departure?

20.11.2026 11:48

Anthropic's IPO Triggered a Sell-Off of Chipmakers' Stocks in Asia. What Should Investors Do?

20.11.2026 11:20

Top Stories This Morning: Anthropic's Debut, a Sale in Asia, Another IPO Cancellation, and Apple's AI Agent

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026